1 year return (CAGR)
8.54%
Eledon Pharmaceuticals Inc Exchange (NASDAQ, USD)
ELDN
2.89
-0.04 (-1.48%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
26.47%
5 year return (CAGR)
-19.17%
10 year return (CAGR)
-33.99%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
216.97M
Price/Sales
-
Ent value
264.23M
Price/Book
3.01
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-49.53%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.71 |
| Daily high | 2.72 |
| Daily low | 2.64 |
| Daily Volume | 737K |
| All-time high | 3202.74 |
| 1y analyst estimate | 9.00 |
| Beta | 0.96 |
| EPS (TTM) | -0.87 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ELDN | S&P500 | |
| Current price drop from All-time high | -99.91% | -0.58% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 29 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -90.59% | -10.68% |
| Avg time to new high | 1508 days | 12 days |
| Max time to new high | 3016 days | 1805 days |
News
